Shares of Humana Inc. (NYSE:HUM) were up 1.3% on Tuesday . The company traded as high as $176.60 and last traded at $176.33, with a volume of 607,412 shares changing hands. The stock had previously closed at $174.00.

A number of analysts have weighed in on HUM shares. Cowen and Company reissued an “outperform” rating on shares of Humana in a report on Tuesday, April 5th. Leerink Swann reissued an “outperform” rating on shares of Humana in a report on Tuesday, April 5th. Zacks Investment Research downgraded shares of Humana from a “hold” rating to a “sell” rating in a report on Tuesday, April 12th. Stifel Nicolaus increased their price target on shares of Humana from $209.00 to $220.00 and gave the company a “buy” rating in a report on Thursday, May 5th. Finally, Royal Bank Of Canada increased their price target on shares of Humana from $209.00 to $220.00 and gave the company a “sector perform” rating in a report on Thursday, May 5th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company’s stock. Humana has an average rating of “Hold” and a consensus price target of $210.60.

The stock has a market capitalization of $26.82 billion and a price-to-earnings ratio of 25.09. The stock has a 50 day moving average price of $181.12 and a 200 day moving average price of $175.78.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.81 by $0.05. The business earned $13.80 billion during the quarter, compared to the consensus estimate of $13.80 billion. The company’s revenue was down .2% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.58 EPS. On average, equities analysts expect that Humana Inc. will post $8.87 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Stockholders of record on Thursday, June 30th will be given a $0.29 dividend. The ex-dividend date of this dividend is Tuesday, June 28th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.64%.

A number of large investors have recently bought and sold shares of the company. Wellington Shields Capital Management LLC boosted its stake in Humana by 17.1% in the fourth quarter. Wellington Shields Capital Management LLC now owns 5,935 shares of the insurance provider’s stock valued at $1,059,000 after buying an additional 865 shares in the last quarter. Commerzbank Aktiengesellschaft FI boosted its stake in Humana by 52.0% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 8,869 shares of the insurance provider’s stock valued at $1,583,000 after buying an additional 3,035 shares in the last quarter. Tredje AP fonden boosted its stake in Humana by 1.7% in the fourth quarter. Tredje AP fonden now owns 9,477 shares of the insurance provider’s stock valued at $1,694,000 after buying an additional 158 shares in the last quarter. Gamco Investors INC. ET AL boosted its stake in Humana by 12.1% in the fourth quarter. Gamco Investors INC. ET AL now owns 9,620 shares of the insurance provider’s stock valued at $1,717,000 after buying an additional 1,040 shares in the last quarter. Finally, Deere & Co. boosted its stake in Humana by 791.1% in the fourth quarter. Deere & Co. now owns 10,078 shares of the insurance provider’s stock valued at $1,799,000 after buying an additional 8,947 shares in the last quarter.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.